Ephenidine Dosage Guide

## Recognizing a Dangerous Situation Ephenidine overdose can present as either primarily physical or primarily psychological depending on dose and circumstances. Physical warning signs requiring immediate medical attention: severe nystagmus with complete unresponsiveness, vomiting while unconscious (aspiration risk is the primary acute killer with dissociative overdoses), severely depressed or irregular breathing, seizures, extremely elevated heart rate or blood pressure, and cyanosis (blue-tinged lips or fingernails indicating inadequate oxygenation). Psychological warning signs: complete dissociation from reality persisting beyond the expected 6-8 hour window, severe agitation or panic that cannot be managed with environmental changes and reassurance, catatonic unresponsiveness, or self-harm behavior. ## Emergency Response Place the person in the recovery position immediately — on their side, with the upper leg bent forward to prevent rolling, head tilted to allow fluids to drain from the mouth. This single intervention addresses the aspiration risk that accounts for most dissociative-related deaths. Monitor breathing continuously. Call emergency services if breathing becomes slow, shallow, or irregular; if the person cannot be roused by voice or physical stimulation; if vomiting occurs while unconscious; or if seizures occur. Be honest with medical personnel about what was consumed. Ephenidine is obscure enough that clinicians will almost certainly be unfamiliar with it. Providing the compound name, noting that it is a diarylethylamine NMDA antagonist with a 6-8 hour duration, and stating the approximate dose and time of ingestion gives the medical team the information they need. There is no specific pharmacological antagonist for ephenidine — treatment is entirely supportive, focused on airway management, monitoring, and symptomatic care. ## Why Ephenidine Overdoses Happen The slow onset is the primary culprit. Users expecting effects within 30-45 minutes (as with ketamine or many other dissociatives) redose at 60 minutes when they feel nothing, then experience both doses simultaneously at the 90-120 minute mark. This pattern is documented repeatedly in community reports. The second common pathway is underestimating the dose conversion between routes — vaporization requires roughly 20% of the oral dose, and users transitioning from oral to vaporized administration without adjusting their dose can dramatically overshoot.